morphine sulfate 20 MG/ML Oral Solution

What the CMS Formulary Data Shows for morphine sulfate 20 MG/ML Oral Solution

Per the CMS 2026 Part D formulary file, morphine sulfate 20 MG/ML Oral Solution (RxNorm concept RXCUI 892625, generic name morphine sulfate) appears on 303 distinct formulary files spanning 4,953 Medicare Part D plan offerings - 97.8% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.3.

Real-world access to morphine sulfate 20 MG/ML Oral Solution depends on utilization management as much as tier placement: 16.8% of covering formularies require prior authorization. 0% require step therapy. 83.5% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 255,247 Part D beneficiaries filled morphine sulfate 20 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $66,058,764 and an average per-beneficiary annual cost of $258.80. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry morphine sulfate 20 MG/ML Oral Solution today.